Home » Prices » NASDAQ:NKTR

Nektar Therapeutics stock price

Today's NASDAQ:NKTR chart, history & news

Price:
17.07 USD
Change:
-0.205 (-1.19%)
Key Stats
Price open 17.24
Previous close 17.275
Market cap 3.06B
Volume 605.01K
Day high 17.4
Day low
Year high 27.96
Year low 14.47
Year to date change -22.10%
P/E Ratio -6.88
Company Profile
Fundamentals
Insider Information
News

About Nektar Therapeutics

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough. The company is engaged in developing a proprietary pipeline of drug candidates for several therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology. The company's research and development involve in small molecule and biologic drug candidates. Its drug candidate base consists of naloxegol , a Phase III oral opioid antagonist, etirinotecan pegol, a topoisomerase inhibitor under Phase III clinical study as of 2012, NKTR 061, NKTR-181, NKTR-214, etc.

Company information

Company name
Nektar Therapeutics
Exchange
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Employees
618
CEO
Howard Robin
Address
455 Mission Bay Blvd S, San francisco, California, 94158-2158
Country
United States
Contact information
14154825300
Website
http://www.nektar.com/

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.